Dr. Cronin-Golomb graduated from the California Institute of Technology in 1984 with a Ph.D. in Psychobiology, after receiving a B.A. in Biology-Psychology from Wesleyan University. She joined Boston University in 1989 and is a faculty member in the Department of Psychological and Brain Sciences (in both the Clinical Program and the Program in Brain, Behavior, and Cognition) as well as the interdisciplinary Center for Systems Neuroscience and Neurophotonics Center. She is director (along with Dr. Michael Lyons) of the Center for Clinical Biopsychology and is director of the Vision and Cognition Laboratory. Dr. Cronin-Golomb’s group collaborates with faculty from the Charles River Campus where she is based, including the College of Health and Rehabilitation Sciences: Sargent College, and with faculty from the Medical Campus; the VA Boston Healthcare System; and the BU-affiliated Framingham Heart Study, the latter in regard to disease biomarkers. She teaches courses at the undergraduate and graduate level in Neuropsychology.

Dr. Cronin-Golomb’s principal research focus is on the neural correlates of perception and cognition in aging and age-related neurodegenerative disease. Her main methodology is behavioral and includes visual psychophysics, neuropsychological assessment, and sensory/cognitive neuroscience, with collaborators in neuroimaging. A current emphasis is on the non-motor symptoms of Parkinson’s disease (perception, cognition, attention, mood, stigma, sleep, circadian function, autonomic function) and their interaction with motor symptoms, with attention to motor subtypes (e.g., body side of PD onset, type of symptom at onset). Her lab engages in basic research and in the development of interventions to enhance quality of life. Dr. Cronin-Golomb also has a long-standing interest in perception and cognition in Alzheimer’s disease. Her work and that of her students is supported by the National Institute of Health, the American Parkinson’s Disease Association, the Boston University Interdisciplinary Biomedical Research Office Affinity Research Collaborative (ARC), the Boston University Alzheimer Disease Center, and the Boston University Digital Health Initiative.